Jim Tyminski practices intellectual property law, with a focus on Hatch-Waxman patent litigation. Jim has extensive experience litigating patents covering polymorphic and solvated forms of active pharmaceutical ingredients. He has defended various patents covering novel pharmaceutical formulations, particularly oral and topical dosage forms.
At Rutgers University, Jim worked in Dr. Eddy Arnold’s laboratory at the Center for Advanced Biotechnology and Medicines. His undergraduate research and senior thesis focused on crystallization and structure determination of human capping enzyme and antiretroviral drugs, which led to a published article in Proceedings of the National Academy of Sciences.